Nasal Polyps Treatment
According to Intent Market Research, the Nasal Polyps Treatment Market is expected to grow from USD 3.0 Billion in 2024-e at a CAGR of 27.2% to touch USD 12.5 Billion by 2030. The Nasal Polyps Treatment Market is dominated by key players such as Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., AstraZeneca PLC, Novartis International AG, and Teva Pharmaceuticals